Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marriott International Inc (MAR) vs Revvity Inc (RVTY) Price & Performance

Marriott International Inc Trade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Marriott International Inc vs Revvity Inc — how do they compare? Marriott International Inc trades at $356 (market cap $91.14B), while Revvity Inc trades at $115.49 (market cap $12.91B). The key difference: Marriott International Inc is far larger — about 7.1× Revvity Inc's market cap, and Marriott International Inc pays the higher dividend (0.84%). Which is the better fit depends on your goals.

MARRVTY
Market Cap
$91.14B$12.91B
Sector
Consumer CyclicalTechnology
52-Week High
$402.54$117.75
52-Week Low
$259.04$82.26
Enterprise Value
$108.45B$15.23B
Dividend Yield
0.84%0.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marriott International Inc

Marriott International (MAR) trades at $348.44, down 1.55% on the day, with a bearish technical signal and mixed earnings performance. The company reported Q2 2026 EPS of $3.19, beating estimates, but revenue growth faces headwinds. Key risks include high debt levels and valuation concerns, while analyst consensus remains positive with a $387.31 price target.

Outlook: MAR's fee-based model and loyalty program drive growth, but elevated P/E of 36.18 and rising debt-to-asset ratio warrant caution. Upside hinges on sustained RevPAR gains and effective cost management amid global economic uncertainty.

Revvity Inc

RVTY trades at $115.18, down 0.72% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings of $1.41 per share, beating estimates, and raised its full-year outlook, driven by diagnostics strength and AI-enabled drug discovery. Revenue for 2025 was $2.86 billion with a net income margin of 8.16%, though valuation ratios like P/E of 55.64 appear elevated. Recent news includes product launches like the SuperFlex prenatal system and presentations at investor conferences.

The outlook is positive with analyst consensus favoring a buy rating and a $120.50 price target, suggesting upside. Key opportunities include robust diagnostics demand and innovation pipelines, while risks involve high valuation multiples and competitive pressures in the healthcare sector. Cash flow improved in 2026 to a net positive $31 million, supporting growth initiatives.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Marriott International Inc

Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.

Read more on MAR

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY